A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

According to the Centers for Disease Control and Prevention (CDC), there have been 67 confirmed human cases of H5N1 bird flu ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

Robert F. Kennedy Jr., told senators Thursday he would support the development and distribution of avian flu vaccines for ...

The escalating bird flu crisis is ravaging the nation's egg supply, and that shortage has hit Arizona along with the rest of ...

Merck stands to lose $62 billion over four years following the loss of exclusivity on KEYTRUDA, making Moderna's $13 billion market cap a bargain. The worsening Avian Flu crisis adds optionality ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

This latest financial support comes on top of the $176 million BARDA gave Moderna last summer. “Avian flu variants have proven to be particularly unpredictable and dangerous to humans in the past.